Delayed Japan Exchange 02:00:00 2024-04-30 am EDT 5-day change 1st Jan Change
1,276 JPY +1.59% Intraday chart for Nipro Corporation +1.43% +15.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jefferies Adjusts Nipro’s Price Target to 1,400 Yen From 1,200 Yen, Keeps at Hold MT
Jefferies Adjusts Nipro's Price Target to 1,200 Yen From 1,000 Yen, Keeps at Hold MT
Jefferies Adjusts Nipro’s Price Target to 1,000 Yen From 1,100 Yen, Keeps at Hold MT
Nipro Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Nanotis Corporation announced that it has received funding from Nipro Corporation CI
Shinsei Bank : Japan's Topix hits highest since 1990 on hopes of new govt, better earnings RE
SBI : Japan shares rally on, Topix hits over 30-year high on earnings optimism RE
Azgard Nine : Japan to consider sharing COVID-19 vaccines amid calls to help Taiwan RE
AstraZeneca : Nipro to Manufacture AstraZeneca's COVID-19 Vaccine in Japan MT
AstraZeneca : Nipro sign COVID-19 vaccine deal for supply in Japan RE
Qol Holdings Co., Ltd. acquired remaining 49% stake in Nichihos Co.,Ltd. from Nipro Corporation. CI
Nipro : Syringe shortage hampers Japan's COVID-19 vaccination roll out RE
Nippon Electric Glass : Glass maker Schott predicts enough vials to go around for COVID-19 vaccines RE
Exclusive: Bottlenecks? Glass vial makers prepare for COVID-19 vaccine RE
JMI Syringes & Medical Devices Limited announced that it has received BDT 1.82151 billion in funding from Nipro Corporation CI
Nagase & Co., Ltd. cancelled the acquisition of 5% stake in Yuki Gosei Kogyo Co., Ltd. from Nipro Corporation. CI
JMI Syringes & Medical Devices Limited announced that it expects to receive BDT 1.82151 billion in funding from Nipro Corporation CI
Tranche Update on Nipro Corporation's Equity Buyback Plan announced on July 3, 2018. CI
Nipro Corporation's Equity Buyback announced on July 3, 2018 has expired with 3,520,600 shares for ¥4,999.92 million. CI
Tranche Update on Nipro Corporation's Equity Buyback Plan announced on July 3, 2018. CI
Samsung Electronics Plans To Sell Medical Unit To Nipro CI
Nipro Corporation announces an Equity Buyback for 4,000,000 shares, representing 2.4% for ¥5,000 million. CI
Nipro Corporation authorizes a Buyback Plan. CI
Nipro Corporation Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2018 and Year Ending March 31, 2019 CI
Nagase & Co., Ltd. agreed to acquire 5% stake in Yuki Gosei Kogyo Co., Ltd. from Nipro Corporation for approximately ¥380 million. CI
Chart Nipro Corporation
More charts
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1,276 JPY
Average target price
1,475 JPY
Spread / Average Target
+15.60%
Consensus
  1. Stock Market
  2. Equities
  3. 8086 Stock
  4. News Nipro Corporation
  5. Jefferies Adjusts Nipro’s Price Target to 1,000 Yen From 1,100 Yen, Keeps at Hold